October 15, 2019 Valens Reports Record Revenue, Adjusted EBITDA and Profitability for the Third Quarter of Fiscal 2019
October 9, 2019 Valens to Hold Conference Call to Discuss Financial Results for the Third Quarter of Fiscal 2019
September 23, 2019 Valens Receives Amended License from Health Canada Permitting Sales Directly to Provinces and Territories & Provides Operational Update
September 12, 2019 Valens Announces Five Year White Label Cannabis Infused Beverage Contract With Iconic Brewing Company’s Cannabis Division
September 10, 2019 Valens Announces Record Third Quarter 2019 Revenue Guidance and Participation in Live Investor Webcast on September 12th
July 15, 2019 Valens Reports Record $8.8 Million in Revenue and Adjusted EBITDA of $2.0 Million in the Second Quarter of Fiscal 2019
July 9, 2019 Valens to Hold Conference Call to Discuss Financial Results for the Second Quarter of Fiscal 2019
Extract
Test
